Privi Speciality Chemicals Limited carries a market capitalization of 142.52B, placing it among publicly traded companies globally. Its enterprise value stands at 88.70B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 142.52B |
| Enterprise Value | 88.70B |
Privi Speciality Chemicals Limited trades at a trailing price-to-earnings ratio of 40.77.
| PE Ratio | 40.77 |
| PS Ratio | 4.04 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Privi Speciality Chemicals Limited trades at an EV/EBITDA multiple of 24.96 and an EV/FCF ratio of 137.58. The EV/Sales ratio of 4.04 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 24.96 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.04 |
| EV / EBITDA | 24.96 |
| EV / EBIT | 24.96 |
| EV / FCF | 137.58 |
Privi Speciality Chemicals Limited maintains a current ratio of 2.47, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 206.54, indicating elevated leverage, while an interest coverage ratio of 3.97 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 2.47 |
| Quick Ratio | 0.08 |
| Debt / Equity | 206.54 |
| Debt / EBITDA | N/A |
| Interest Coverage | 3.97 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 28.73 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Privi Speciality Chemicals Limited has paid 819.34M in income taxes, reflecting an effective tax rate of 27.98.
| Income Tax | 819.34M |
| Effective Tax Rate | 27.98 |
Privi Speciality Chemicals Limited's stock has gained approximately 54.59514% over the past 52 weeks. The 50-day moving average sits at 3,367.78, while the 200-day moving average is 3,026.70.
| Beta (5Y) | N/A |
| 52-Week Price Change | 54.59514% |
| 50-Day Moving Average | 3,367.78 |
| 200-Day Moving Average | 3,026.70 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Privi Speciality Chemicals Limited generated 21.96B in revenue and converted that into 2.18B in net income, yielding earnings per share of 53.97. EBITDA reached 3.55B, while operating income came in at 3.55B.
| Revenue | 21.96B |
| Gross Profit | 10.50B |
| Operating Income | 3.55B |
| Pretax Income | 2.93B |
| Net Income | 2.18B |
| EBITDA | 3.55B |
| EBIT | 3.55B |
| Earnings Per Share (EPS) | 53.97 |
Privi Speciality Chemicals Limited operates with a gross margin of 47.81, reflecting its pricing power and cost economics. The operating margin of 16.18 and net profit margin of 9.91 provide insight into operational efficiency.
| Gross Margin | 47.81 |
| Operating Margin | 16.18 |
| Pretax Margin | 13.33 |
| Profit Margin | 9.91 |
| EBITDA Margin | 16.18 |
Privi Speciality Chemicals Limited posts an Altman Z-Score of 7.62, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 7.62 |